Partner Headlines - EXEL

  1. Day Trading Stock Picks for This Week - Tuesday, Jan. 17

    TalkMarkets
  2. 4 Biotech Stocks That More Than Doubled In 2016

    TalkMarkets
  3. Zoetis Tops Q3 Earnings Estimates, Updates Outlook

    TalkMarkets
  4. J&J Outshines in Q3 Earnings on Strong Pharma Sales

    TalkMarkets
  5. Will These 5 Drug Stocks Be Big Winners This Earnings Season?

    TalkMarkets
  6. Exelixis - Chart Of The Day - September 26, 2016

    TalkMarkets
  7. Benzinga's Top #PreMarket Gainers

    Benzinga
  8. 5 Stocks You Should Be Watching Today

    Benzinga
  9. The Best-Performing Non-S&P Stocks of 2015

    GuruFocus
  10. Top-Performing Non-S&P 500 Stocks of the Year

    GuruFocus
  11. Top Stocks 2015: Biotechs, Wayfair, Netflix, Amazon

    IBD
  12. Exelixis Announces Presentation of Positive Overall Survival ...

    Benzinga
  13. Morning Market Gainers

    Benzinga
  14. Benzinga's Top #PreMarket Gainers

    Benzinga
  15. Exelixis Announces Positive Overall Survival Results from coBRIM ...

    Benzinga
  16. Morning Market Losers

    Benzinga
  17. Benzinga's Top #PreMarket Losers

    Benzinga
  18. Jim Cramer Shares His Thoughts On Home Depot, Bristol-Myers Squibb, ...

    Benzinga
  19. Morning Market Gainers

    Benzinga
  20. Benzinga's Top #PreMarket Gainers

    Benzinga
  21. Benzinga's Top #PreMarket Gainers

    Benzinga
  22. Exelixis Prices 25M Share Offering @$5.40/Share

    Benzinga
  23. Benzinga's Top #PreMarket Losers

    Benzinga
  24. Ethical-Drug Firms Horizon Pharma, Bristol-Myers Rally

    IBD
  25. Bristol-Myers: kidney drug win

    IBD
  26. Market Update: Monday's Mid-Day Movers; Greece Opens Banks; Gold ...

    Benzinga
  27. Bristol-Myers, Exelixis Drugs Score Vs. Kidney Cancer

    IBD
  28. Mid-Morning Market Update: Markets Mostly Flat; Morgan Stanley ...

    Benzinga
  29. Benzinga's Top #PreMarket Gainers

    Benzinga
  30. Exelixis Announces Start of Phase 1 Trial of Cabozantinib in ...

    Benzinga
  31. Benzinga's Top #PreMarket Losers

    Benzinga
  32. Watch These 10 Stocks Over The Weekend

    Benzinga
  33. Morning Market Gainers

    Benzinga
  34. Benzinga's Top #PreMarket Gainers

    Benzinga
  35. Morning Market Gainers

    Benzinga
  36. Benzinga's Top #PreMarket Gainers

    Benzinga
  37. Exelixis Data Release Upcoming; Options Activity Spiking

    Benzinga
  38. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  39. 5-year lows: Synta Pharmaceuticals Inc, Exelixis Inc, Entropic ...

    GuruFocus
  40. Mid-Day Market Update: ON Semiconductor Surges On $1 Billion ...

    Benzinga
  41. Mid-Morning Market Update: Markets Open Lower; Weatherford To ...

    Benzinga
  42. Morning Market Losers

    Benzinga
  43. Events for the Week of Nov. 17-21, 2014

    Benzinga
  44. Morning Market Movers

    Benzinga
  45. 5-year lows: National Presto Industries, Ennis Inc, Landauer ...

    GuruFocus
  46. Stocks Hitting 52-Week Lows

    Benzinga
  47. Equities, Commodities & Bonds Finish Lower On First Trading Day ...

    Benzinga
  48. Midday Losers From Tuesday, September 2

    Benzinga
  49. Exelixis Shares Slide On Trial Results; Norwegian Cruise Line ...

    Benzinga
  50. Markets Mixed; Conn's Profit Misses Estimates

    Benzinga
  51. Stocks Hitting 52-Week Lows

    Benzinga
  52. Morning Market Losers

    Benzinga
  53. Benzinga's Top Downgrades

    Benzinga
  54. Stifel Nicolaus Downgrades Exelixis To Hold

    Benzinga
  55. Stocks To Watch For September 2, 2014

    Benzinga
  56. Exelixis Announces Results From COMET-1 Phase 3 Pivotal Trial ...

    Benzinga
  57. Mid-Afternoon Market Update: Harmonic Drops On Weak Forecast; ...

    Benzinga
  58. Harmonic Drops On Weak Forecast; URS Shares Surge

    Benzinga
  59. Mid-Morning Market Update: Markets Open Higher; Citigroup Profit ...

    Benzinga
  60. Morning Market Movers

    Benzinga
  61. Exelixis Shares Move 12% On Phase 3 Data

    Benzinga
  62. Benzinga's Top #PreMarket Gainers

    Benzinga
  63. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga
  64. Benzinga's Top #PreMarket Gainers

    Benzinga
  65. Five-Year Lows: Rentech Nitrogen Partners LP, SandRidge Permian ...

    GuruFocus
  66. Market Wrap For March 26: Markets Close Near Session Lows In ...

    Benzinga
  67. Mid-Afternoon Market Update: Markets Turn Red as Dish Network ...

    Benzinga
  68. Mid-Day Market Update: Five Below Jumps On Upbeat Results; Exelixis ...

    Benzinga
  69. Mid-Morning Market Update: Markets Open Higher; Francesca's Issues ...

    Benzinga
  70. Stocks Hitting 52-Week Lows

    Benzinga
  71. Morning Market Losers

    Benzinga
  72. Benzinga's Top #PreMarket Losers

    Benzinga
  73. Morning Market Movers

    Benzinga
  74. US Stock Futures Rise Ahead Of Housing Data

    Benzinga
  75. Exelixis Prices 10M Share Offering at $8 per Share

    Benzinga
  76. Oversold ETFs Looking Attractive (IHE, CSD, PSCE)

    Benzinga
  77. Exelixis Announces Promising Phase 1b Data for Cobimetinib in ...

    Benzinga
  78. US Stock Futures Rise Ahead Of Jobless Claims, GDP Data

    Benzinga
  79. Exelixis Announces Full Patient Enrollment for COMET-1 Phase ...

    Benzinga
  80. US Stock Futures Up After Upbeat China Data

    Benzinga
  81. Exelixis Initiates Phase 3 Clinical Trial of Cabozantinib

    Benzinga
  82. Exelixis Receives EMA Acceptance of Marketing Authorization App ...

    Benzinga
  83. Exelixis Inc. Reports Operating Results (10-Q)

    GuruFocus
  84. Exel Presents Interim Data for Cabozantinib 40 mg Dose Cohort ...

    Benzinga
  85. First Solar, Sears Holdings Among Stocks Down on Above-average ...

    FoxBusiness
  86. Exelixis Says FDA Says NDA Has Been Removed from November Agenda

    Benzinga
  87. UPDATE: Piper Jaffray Reduces PT to $4.50 on Exelixis on Equity ...

    Benzinga
  88. Social Media Outlook for Thursday August 9 (EAT, NOV, NWSA, FSYS)

    Benzinga
  89. Exelixis, Universal Display Corporation Among Stocks Up on High ...

    FoxBusiness
  90. FDA's Oncologic Drugs Advisory Committee to Review Exelixis New ...

    Benzinga
  91. Exelixis (EXEL) Loses 8.8% As Company Sells Stock, Debt

    MarketIntelligenceCenter
  92. Health Care Sector Wrap

    FoxBusiness
  93. HCA Holdings, American Capital Mortgage Investment Crp Among ...

    FoxBusiness
  94. Interpublic Group, Exelixis Gapping Down Monday

    FoxBusiness
  95. UPDATE: Exelixis Announces Proposed Convertible Debt Offering ...

    Benzinga
  96. Exelixis Proposed Offering 20M Shares

    Benzinga
  97. Exelixis Inc. Reports Operating Results (10-Q)

    GuruFocus
  98. Social Media Outlook for Monday July 30 (SHAW, BBY, EXEL, VHC)

    Benzinga
  99. Benzinga's Top Pre-Market Gainers

    Benzinga
  100. FDA Grants Priority Review for Cabozantinib in Medullary Thyroid ...

    Benzinga
Trading Center